Locations:
SearchCleveland Clinic Cole Eye Institute is proud to share highlights from 2025. Read on for notable news, research insights, and more on how we support patient health and well-being.
Preclinical study shows why it’s critical to consider sex in eye disease research
Advertisement
CFH gene triggers the eye disease in white patients but not Black patients
It’s the first step toward reliable screening with your smartphone
Registry data highlight visual gains in patients with legal blindness
Evidence mounts that these diabetes and obesity drugs may protect eyes, not endanger them
Watch for sudden unilateral vision loss without pain
Prescribing eye drops is complicated by unknown risk of fetotoxicity and lack of clinical evidence
From medication to laser treatment to surgery
Prematurity is linked with poorer outcomes of retinal surgery in adulthood
Study is first to show reduction in autoimmune disease with the common diabetes and obesity drugs
Study identifies factors that may predict vision outcomes in diabetic macular edema
New insights on effectiveness in patients previously treated with other anti-VEGF drugs
Oral medication may have potential to preserve vision and shrink tumors prior to surgery or radiation
Treatment options range from tetracycline injections to fat repositioning and cheek lift
7 keys to success for comprehensive ophthalmologists
A primer on MIGS methods and devices
The advanced stage of diabetic retinopathy is among the most challenging for retinal surgeons
A look at emerging technology shaping retina surgery
Advertisement
Advertisement